Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Loncar Cancer Immunotherapy ETF (NQ: CNCR )

14.65 +0.23 (+1.61%)
Official Closing Price Updated: 4:15 PM EDT, Sep 30, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 996
Open 14.92
Bid (Size) 14.61 (1)
Ask (Size) 14.69 (1)
Prev. Close 14.42
Today's Range 14.65 - 14.92
52wk Range 12.76 - 30.56
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
5 ETFs Riding High On The Biotech Comeback
The high-growth biotech segment has borne the maximum brunt of the broader market sell-off. 
Via Talk Markets
3 Promising Oncology Stocks To Consider Adding To Your Portfolio
With tech integration and DNA sequencing increasing the efficacy of potential cancer drugs in the pipeline, we believe biotech names AstraZeneca, Amgen and Incyte are worth adding to a portfolio. 
Via Talk Markets

Performance

YTD
-39.33%
-39.33%
1 Month
-5.51%
-5.51%
3 Month
-5.46%
-5.46%
6 Month
-23.45%
-23.45%
1 Year
-52.05%
-52.05%

More News

Read More
Best Biotech Stocks & ETFs for mRNA, Gene Editing
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.